Key result
Secondary prevention after acute coronary syndromes requires a shift towards multidisciplinary, patient-centered models to address suboptimal prognosis and high treatment costs.
Population
Patients after acute coronary syndromes
Design
Review
Authors
Loading...
May support multidisciplinary ACS secondary prevention models; leaves open prospective trials on outcomes and costs.
This review emphasizes the need to integrate innovative pharmacological therapies with patient-centered, multidisciplinary approaches to optimize secondary prevention after acute coronary syndromes.
Cortés-Beringola et al. (2017) conducted a review in Acute coronary syndromes. Secondary prevention strategies was evaluated. Secondary prevention after acute coronary syndromes requires a shift towards multidisciplinary, patient-centered models to address suboptimal prognosis and high treatment costs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: